Country Profile

Honduras

Honduras is an emerging destination for Indian pharmaceutical exports — $41.4M in FY 2025–26, with 4.2× growth over the past decade. Medicines accounts for 82% of shipments, with vaccines contributing $5.25M. The compound annual growth rate since FY2015 stands at 14.0%.

🇭🇳 $41.4M · 4.2× growth since FY2015 · 14.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$41.4M
Exports FY2025–26 DGCIS
4.2×
Growth FY2015→2026
14.0%
CAGR FY2015→2026
82%
Medicines Share
5
Product Categories Supplied
Honduras is an emerging destination for Indian pharmaceutical exports — $41.4M in FY 2025–26, with 4.2× growth over the past decade. Medicines accounts for 82% of shipments, with vaccines contributing $5.25M. The compound annual growth rate since FY2015 stands at 14.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $34.1M (82.3%) Vaccines $5.25M (12.7%) Surgical & Hospital Supplies $1.37M (3.3%) Medicine Ingredients $553K (1.3%) Traditional & Herbal $171K (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Honduras in the RBI overseas direct investment dataset (2011–2026).